CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT - USD ($)	Common Stock [Member] Class A Ordinary Shares [Member]	Common Stock [Member] Class B Ordinary Shares [Member]		Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Mar. 21, 2024	$ 0	$ 0		$ 0	$ 0	$ 0
Beginning balance (in Shares) at Mar. 21, 2024	0	0
Issuance of Class B ordinary shares to Sponsor	$ 0	$ 216		24,784	0	25,000
Issuance of Class B ordinary shares to Sponsor (in Shares)	0	2,156,250	[1]
Net income (loss)	$ 0	$ 0		0	(15,397)	(15,397)
Ending balance at Mar. 31, 2024	$ 0	$ 216		24,784	(15,397)	9,603
Ending balance (in Shares) at Mar. 31, 2024	0	2,156,250	[1]
Beginning balance at Mar. 21, 2024	$ 0	$ 0		0	0	0
Beginning balance (in Shares) at Mar. 21, 2024	0	0
Net income (loss)						87,478
Ending balance at Jun. 30, 2024	$ 29	$ 216		0	(1,744,312)	(1,744,067)
Ending balance (in Shares) at Jun. 30, 2024	286,250	2,156,250
Beginning balance at Mar. 31, 2024	$ 0	$ 216		24,784	(15,397)	9,603
Beginning balance (in Shares) at Mar. 31, 2024	0	2,156,250	[1]
Accretion for Class A ordinary shares to redemption amount	$ 0	$ 0		(2,871,286)	(1,831,790)	(4,703,076)
Sale of Private Placement Shares	$ 29	$ 0		2,862,471	0	2,862,500
Sale of Private Placement Shares (in Shares)	286,250	0
Allocated value of transaction costs to Class A shares	$ 0	$ 0		(15,969)	0	(15,969)
Net income (loss)	0	0		0	102,875	102,875
Ending balance at Jun. 30, 2024	$ 29	$ 216		0	(1,744,312)	(1,744,067)
Ending balance (in Shares) at Jun. 30, 2024	286,250	2,156,250
Beginning balance at Dec. 31, 2024	$ 29	$ 216		0	(2,116,366)	(2,116,121)
Beginning balance (in Shares) at Dec. 31, 2024	286,250	2,156,250
Accretion for Class A ordinary shares to redemption amount	$ 0	$ 0		0	(934,513)	(934,513)
Net income (loss)	0	0		0	678,555	678,555
Ending balance at Mar. 31, 2025	$ 29	$ 216		0	(2,372,324)	(2,372,079)
Ending balance (in Shares) at Mar. 31, 2025	286,250	2,156,250
Beginning balance at Dec. 31, 2024	$ 29	$ 216		0	(2,116,366)	(2,116,121)
Beginning balance (in Shares) at Dec. 31, 2024	286,250	2,156,250
Net income (loss)						1,433,402
Ending balance at Jun. 30, 2025	$ 29	$ 216		0	(2,265,520)	(2,265,275)
Ending balance (in Shares) at Jun. 30, 2025	286,250	2,156,250
Beginning balance at Mar. 31, 2025	$ 29	$ 216		0	(2,372,324)	(2,372,079)
Beginning balance (in Shares) at Mar. 31, 2025	286,250	2,156,250
Accretion for Class A ordinary shares to redemption amount	$ 0	$ 0		0	(648,043)	(648,043)
Net income (loss)	0	0		0	754,847	754,847
Ending balance at Jun. 30, 2025	$ 29	$ 216		$ 0	$ (2,265,520)	$ (2,265,275)
Ending balance (in Shares) at Jun. 30, 2025	286,250	2,156,250

[1] This number includes up to 281,250 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Notes 4 and 6). On June 13, 2024, the underwriter exercised its over-allotment option in full as part of the closing of the Initial Public Offering. As such, 281,250 Founder Shares were no longer subject to forfeiture.